Free tool
FAERS Monitor: Magnesium Sulfate In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020309 or its brand name (Magnesium Sulfate In Plastic Container, Magnesium Sulfate). Reports on generic versions are filed under their own applications.
Reports
17
Serious
13
76% of reports
Hospitalization
11
Death reported
1
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- burkholderia test positive8
- endotracheal intubation5
- dyspnoea4
- covid-193
- no adverse event3
- respiratory rate decreased3
- extrapyramidal disorder2
- respiratory failure2
- therapeutic product effect increased2
- tremor2
- acute kidney injury1
- acute respiratory failure1
- alcoholic pancreatitis1
- atrial fibrillation1
- bacterial infection1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 13 |
| 2024 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,142 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| burkholderia test positiveSignal | 8 | 85412.3 | 49971.3 | 561,799 |
| alcoholic pancreatitis | 1 | 6383.9 | 948.5 | 1,587 |
| endotracheal intubationSignal | 5 | 2210.8 | 1057.6 | 8,930 |
| therapeutic product effect increased | 2 | 2129.8 | 578.6 | 2,389 |
| respiratory rate decreasedSignal | 3 | 1182.9 | 423.3 | 2,457 |
| extrapyramidal disorder | 2 | 99.7 | 27.1 | 109 |
| bacterial infection | 1 | 66.3 | 9.9 | 16 |
| acute respiratory failure | 1 | 64.3 | 9.6 | 15 |
| respiratory failure | 2 | 33.9 | 9.2 | 35 |
| covid-19Signal | 3 | 21.2 | 7.6 | 40 |
| no adverse eventSignal | 3 | 20.5 | 7.3 | 38 |
| tremor | 2 | 14.9 | 4.1 | 14 |
| atrial fibrillation | 1 | 12.7 | 1.9 | 2 |
| dyspnoeaSignal | 4 | 8.7 | 3.7 | 21 |
| acute kidney injury | 1 | 8.1 | 1.2 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.